BIOQ Bioqual, Inc.
Stock · OTC Markets OTCID · United States · Healthcare · US09065J1016
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Bioqual, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD.
Updated 06 Nov 2026 21:06. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 04 Apr 2024 | 80.00 | 80.00 | 80.00 | 80.00 | 0.00% | — | |
| 03 Apr 2024 | 80.00 | 80.00 | 80.00 | 80.00 | 0.00% | — | |
| 02 Apr 2024 | 80.00 | 80.00 | 80.00 | 80.00 | 0.00% | — | |
| 01 Apr 2024 | 80.00 | 80.00 | 80.00 | 80.00 | 0.00% | — | |
| 28 Mar 2024 | 80.00 | 80.00 | 80.00 | 80.00 | 0.00% | — | |
| 27 Mar 2024 | 80.00 | 80.00 | 80.00 | 80.00 | 0.00% | — | |
| 26 Mar 2024 | 80.00 | 80.00 | 80.00 | 80.00 | 0.00% | — | |
| 25 Mar 2024 | 80.00 | 80.00 | 80.00 | 80.00 | 0.00% | — | |
| 22 Mar 2024 | 80.00 | 80.00 | 80.00 | 80.00 | 0.00% | — | |
| 21 Mar 2024 | 80.00 | 80.00 | 80.00 | 80.00 | 0.00% | — | |
| 20 Mar 2024 | 80.00 | 80.00 | 80.00 | 80.00 | 0.00% | — | |
| 19 Mar 2024 | 80.00 | 80.00 | 80.00 | 80.00 | 0.00% | — | |
| 18 Mar 2024 | 80.00 | 80.00 | 80.00 | 80.00 | 0.00% | — | |
| 15 Mar 2024 | 80.00 | 80.00 | 80.00 | 80.00 | 0.00% | — | |
| 14 Mar 2024 | 80.00 | 80.00 | 80.00 | 80.00 | 0.00% | — | |
| 13 Mar 2024 | 80.00 | 80.00 | 80.00 | 80.00 | 0.00% | — | |
| 12 Mar 2024 | 80.00 | 80.00 | 80.00 | 80.00 | +6.31% | 100 | |
| 11 Mar 2024 | 75.25 | 75.25 | 75.25 | 75.25 | 0.00% | — | |
| 08 Mar 2024 | 75.25 | 75.25 | 75.25 | 75.25 | 0.00% | — | |
| 07 Mar 2024 | 75.25 | 75.25 | 75.25 | 75.25 | 0.00% | — | |
| 06 Mar 2024 | 75.00 | 75.25 | 74.80 | 75.25 | +7.50% | 700 | |
| 05 Mar 2024 | 70.00 | 70.00 | 70.00 | 70.00 | 0.00% | — | |
| 04 Mar 2024 | 70.00 | 70.00 | 70.00 | 70.00 | 0.00% | — | |
| 01 Mar 2024 | 70.00 | 70.00 | 70.00 | 70.00 | 0.00% | — | |
| 29 Feb 2024 | 70.00 | 70.00 | 70.00 | 70.00 | 0.00% | — |
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
Key data
- Previous close
- 31.00 USD
- Market cap
- 27.7M
- 5-year average yield
- 1.02%
- Payout ratio
- 15%
- Last dividend
- 0.5000 USD · 07 Oct 2024
- Exchange
- OTC Markets OTCID
- Country
- United States
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 07 Oct 2024 | 0.5000 USD |
| 05 Oct 2023 | 0.5000 USD |
| 05 Oct 2022 | 1.0000 USD |
| 28 Sep 2021 | 1.2500 USD |
| 25 Sep 2020 | 1.1000 USD |
| 24 Sep 2019 | 0.7000 USD |
| 18 Sep 2018 | 0.6000 USD |
| 19 Sep 2017 | 0.6000 USD |
| 03 Oct 2016 | 0.4500 USD |
| 22 Dec 2015 | 0.3500 USD |
| 25 Nov 2014 | 0.2000 USD |
| 26 Nov 2012 | 0.1600 USD |
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 8.8 / 25 No figures for this part: it counts as a cautious 35%. | — |
| Quality Return on equity, net margin and how stable the margins are. | 0.0 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 12.0 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 8.3 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 3.5 / 10 No figures for this part: it counts as a cautious 35%. | — |
- Thinly traded: about 1,054 a day
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 60% of the figures (grade C). Warnings take 6 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 11.83× | Good | 31.09× |
| Price / book | 0.87× | Good | 3.87× |
| Price / sales | 0.69× | Good | 3.42× |
| EV / EBITDA | -16.31× | Weak | 13.09× |
| Free cash flow yield | 0.6% | Weak | 2.5% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 14.8% | Weak | 59.2% |
| Operating margin | -7.9% | Weak | 7.8% |
| Net margin | -11% | Weak | 3.4% |
| Return on equity | -13% | Weak | 5.7% |
| Return on assets | -4.9% | Weak | 3.6% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 1× | Fair | 0.46× |
| Current ratio | 4.17× | Good | 2.35× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 14.6% | Good | 0% |
| Dividend growth / year | 10.3% | Good | 7.1% |
| Years of rising dividends | 0 | Weak | 2 |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow BIOQ and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.